HomePDSB • NASDAQ
add
PDS Biotechnology Corp
Previous close
$1.41
Day range
$1.38 - $1.40
Year range
$1.30 - $6.68
Market cap
51.77M USD
Avg Volume
240.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.18M | -3.24% |
Net income | -10.73M | 1.13% |
Net profit margin | — | — |
Earnings per share | -0.29 | 17.14% |
EBITDA | -10.16M | 3.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 49.75M | -8.29% |
Total assets | 52.45M | -8.28% |
Total liabilities | 30.45M | -6.89% |
Total equity | 22.00M | — |
Shares outstanding | 37.41M | — |
Price to book | 2.35 | — |
Return on assets | -45.06% | — |
Return on capital | -49.91% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.73M | 1.13% |
Cash from operations | -8.00M | -11.48% |
Cash from investing | -1.00 | — |
Cash from financing | 17.22K | -97.85% |
Net change in cash | -7.98M | -25.24% |
Free cash flow | -4.39M | -23.79% |
About
Founded
2005
Website
Employees
25
